花园生物
(300401)
| 流通市值：77.69亿 | | | 总市值：78.97亿 |
| 流通股本：5.35亿 | | | 总股本：5.43亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,064,383,205.02 | 1,055,421,957.77 | 1,284,473,292.97 | 1,097,137,217.54 |
| 交易性金融资产 | 300,957,553.43 | 201,245,320.55 | 140,245,210.96 | 330,000,000 |
| 应收票据及应收账款 | 190,783,760.71 | 186,804,489.45 | 155,616,951.66 | 189,929,382.43 |
| 应收账款 | 190,783,760.71 | 186,804,489.45 | 155,616,951.66 | 189,929,382.43 |
| 应收款项融资 | 1,743,000 | 2,000,000 | 2,080,000 | - |
| 预付款项 | 18,904,700.79 | 12,975,747.42 | 14,165,112.27 | 78,918,396.26 |
| 其他应收款合计 | 3,478,075.2 | 1,227,852.08 | 728,039 | 1,152,280.02 |
| 存货 | 758,418,214.05 | 794,918,289.81 | 838,228,733.15 | 782,158,489.9 |
| 一年内到期的非流动资产 | 45,599.31 | 45,187.01 | 44,778.44 | - |
| 其他流动资产 | 11,533,486.22 | 8,984,319.62 | 33,825,138.49 | 22,889,334.72 |
| 流动资产合计 | 2,350,247,594.73 | 2,263,623,163.71 | 2,469,407,256.94 | 2,502,185,100.87 |
| 非流动资产: | | | | |
| 长期应收款 | 11,467.89 | 22,935.78 | 34,403.67 | - |
| 投资性房地产 | 36,887,932.26 | 37,184,470.89 | 64,490,195.65 | 64,955,248.77 |
| 固定资产 | 2,063,715,174 | 2,098,542,805.85 | 2,125,598,125.88 | 1,980,486,663.49 |
| 在建工程 | 901,249,798.59 | 832,695,329.9 | 661,132,659.43 | 685,801,174.07 |
| 使用权资产 | 64,799.73 | 77,759.67 | 90,719.61 | - |
| 无形资产 | 205,834,728.87 | 207,829,655.45 | 182,727,505.12 | 184,604,185.13 |
| 开发支出 | 40,058,111.37 | 30,892,812.34 | 26,519,321.09 | 18,462,466.74 |
| 递延所得税资产 | 33,603,148.58 | 33,192,109.74 | 36,274,350.31 | 42,916,925.66 |
| 其他非流动资产 | 36,909,564.71 | 32,485,312.25 | 46,370,990.26 | 51,002,937.43 |
| 非流动资产合计 | 3,318,334,726 | 3,272,923,191.87 | 3,143,238,271.02 | 3,028,229,601.29 |
| 资产总计 | 5,668,582,320.73 | 5,536,546,355.58 | 5,612,645,527.96 | 5,530,414,702.16 |
| 流动负债: | | | | |
| 短期借款 | 484,907,576.4 | 291,780,825.4 | 462,793,719.42 | 599,059,622.21 |
| 应付票据及应付账款 | 356,498,331.65 | 369,556,678.35 | 340,537,333.25 | 325,038,470.02 |
| 其中：应付票据 | 21,480,000 | 20,970,000 | 17,011,494.4 | 22,653,735.2 |
| 应付账款 | 335,018,331.65 | 348,586,678.35 | 323,525,838.85 | 302,384,734.82 |
| 预收款项 | 890,130.78 | 1,773,457.68 | 1,897,152.78 | 2,211,864.67 |
| 合同负债 | 13,494,409.29 | 30,510,950.63 | 19,359,573.05 | 17,818,966.48 |
| 应付职工薪酬 | 26,155,130.2 | 12,089,128.8 | 37,760,756.31 | 20,451,884.53 |
| 应交税费 | 22,570,278.44 | 14,790,548.32 | 48,243,071.8 | 40,204,617.17 |
| 其他应付款合计 | 69,555,822.17 | 44,054,558.76 | 70,080,281.85 | 70,247,486.41 |
| 一年内到期的非流动负债 | 203,251,479.63 | 291,592,737.87 | 291,591,853.74 | 93,331,606 |
| 其他流动负债 | 1,750,518.88 | 3,797,974.02 | 2,409,469.44 | 982,685.96 |
| 流动负债合计 | 1,179,073,677.44 | 1,059,946,859.83 | 1,274,673,211.64 | 1,169,347,203.45 |
| 非流动负债: | | | | |
| 长期借款 | 85,073,194.44 | 90,085,250 | 90,015,500 | 198,104,400 |
| 应付债券 | 991,054,936.71 | 974,383,616.48 | 964,246,234.78 | 948,100,950.97 |
| 递延收益 | 28,313,842.92 | 29,677,912.29 | 30,328,968.73 | 32,103,019.39 |
| 递延所得税负债 | 39,319,237.87 | 39,789,856.6 | 34,985,345.5 | 41,607,452.89 |
| 非流动负债合计 | 1,143,761,211.94 | 1,133,936,635.37 | 1,119,576,049.01 | 1,219,915,823.25 |
| 负债合计 | 2,322,834,889.38 | 2,193,883,495.2 | 2,394,249,260.65 | 2,389,263,026.7 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 543,467,766 | 543,467,249 | 543,467,103 | 543,464,130 |
| 其他权益工具 | 258,415,163.13 | 258,416,701.3 | 258,417,140.78 | 258,426,018.16 |
| 资本公积 | -52,939,502.18 | -52,946,370.12 | -53,841,650.56 | -63,350,975.41 |
| 减:库存股 | - | - | 26,861,765 | 26,861,765 |
| 盈余公积 | 240,370,207.07 | 240,370,207.07 | 240,370,207.07 | 217,247,880.01 |
| 未分配利润 | 2,356,440,849.77 | 2,353,360,421.19 | 2,256,849,042.15 | 2,212,228,422.73 |
| 归属于母公司股东权益合计 | 3,345,754,483.79 | 3,342,668,208.44 | 3,218,400,077.44 | 3,141,153,710.49 |
| 少数股东权益 | -7,052.44 | -5,348.06 | -3,810.13 | -2,035.03 |
| 股东权益合计 | 3,345,747,431.35 | 3,342,662,860.38 | 3,218,396,267.31 | 3,141,151,675.46 |
| 负债和股东权益合计 | 5,668,582,320.73 | 5,536,546,355.58 | 5,612,645,527.96 | 5,530,414,702.16 |
| 公告日期 | 2025-08-16 | 2025-04-18 | 2025-03-25 | 2024-10-18 |
| 审计意见(境内) | | | 标准无保留意见 | |